2026-01-02 - Analysis Report
Okay, here's a comprehensive report on Northrop Grumman (NOC) based on the data you provided.

**1) Return Rate Comparison & Analysis**

*   **Company Overview:** Northrop Grumman Corp. is a leading global aerospace and defense technology company.
*   **Cumulative Return (NOC):** 37.27%
*   **Cumulative Return (VOO):** 105.07%
*   **Divergence:** -67.8% (Current).  Relative divergence is 5.1.

**Analysis:**

*   NOC has significantly underperformed the S&P 500 (VOO) over the period examined.
*   The divergence of -67.8% indicates a substantial difference in returns.
*   A relative divergence of 5.1 indicates that the divergence is near its lowest point in the historical data.
*   The alpha, beta analysis provided below shows the details.

**Alpha, Beta Analysis Table**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 32.0% | 73.9% | 3.0% | 0.7 | 35.1 |
| 2017-2019  | 50.0% | 78.4% | 9.0% | 0.7 | 49.2 |
| 2018-2020  | -11.0% | 80.3% | -43.0% | 0.8 | 43.6 |
| 2019-2021  | 40.0% | 80.3% | -36.0% | 0.7 | 55.4 |
| 2020-2022  | 46.0% | 80.8% | 27.0% | 0.6 | 78.1 |
| 2021-2023  | 63.0% | 83.3% | 35.0% | 0.3 | 67.0 |
| 2022-2024  | 27.0% | 83.3% | -3.0% | 0.3 | 67.2 |
| 2023-2025  | 27.0% | 82.0% | -41.0% | 0.1 | 81.6 |

**Analysis:**

*   **CAGR:**  CAGR (Compound Annual Growth Rate) shows the average annual growth rate over the specific periods. Recent CAGR are decent.
*   **MDD:** MDD (Maximum Drawdown) indicates the largest peak-to-trough decline during the period. High MDD values are observed.
*   **Alpha:** Alpha measures the stock's performance relative to the benchmark index (S&P 500) after accounting for risk (Beta). A negative alpha is a bad sign as NOC is underperforming compared to S&P500.
*   **Beta:** Beta measures the stock's volatility relative to the market. A beta of less than 1 indicates lower volatility than the market.
*   **Cap (B):**  Market capitalization in billions of dollars.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 570.21
*   **Previous Close:** 574.57
*   **Change:** -0.76
*   **5-day SMA:** 576.456
*   **20-day SMA:** 566.416
*   **60-day SMA:** 578.423

**Analysis:**

*   The stock price closed lower than the previous day.
*   The 5-day SMA is above the 20-day SMA, which is considered a short-term bullish signal.
*   The 60-day SMA is above the 5-day and 20-day SMAs, indicating a possible long-term bearish trend.

**3) Technical Indicators**

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 59.09
*   **PPO:** 0.2386
*   **Hybrid Signal:**  cash_0%_Buy 100% of cash (3 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) Relative Divergence Change:** -0.5 (Negative - indicating a short-term decline)
*   **Expected Return (%):** 0.0 (No expected excess return compared to S&P 500)

**Analysis:**

*   The MRI suggests that NOC is in a high-investment recommended zone.
*   The RSI (59.09) is approaching the overbought threshold (70), indicating the stock may soon be overvalued.
*   The PPO (Percentage Price Oscillator) is slightly positive, suggesting potential upward momentum.
*   The hybrid signal suggests a bullish stance (100% cash into buying).
*   The expected return of 0.0% is concerning because it means no extra return than S&P 500 if invested for the long term.

**4) Recent News & Significant Events**

*   **Positive Signals:**
    *   Merit Financial Group LLC Purchased Shares of Northrop Grumman Corporation $NOC.
    *   Northrop Grumman Corporation Declares Quarterly Dividend of $2.31 per Share.
*   **Negative Signals:**
    *   Diversified Trust Co Sells 2,245 Shares of Northrop Grumman Corporation $NOC.
    *   Seeking Alpha: Northrop Grumman: An Argument For Buying At Undervaluation (Rating Downgrade).
    *   Yahoo Finance: Why Is Northrop Grumman (NOC) Down 5.3% Since Last Earnings Report?

**Analysis:**

*   The news presents a mixed picture. Some institutions are buying shares or maintaining dividends, while others are selling or downgrading the stock.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.04)
*   **Opinions:** 21
*   **Target Price:** Average: 662.68 / High: 770.00 / Low: 533.00

**Analysis:**

*   Analysts, on average, have a "Buy" rating for NOC.
*   The average target price suggests a potential upside from the current price. However, there is a wide range between the high and low target prices, indicating uncertainty.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-21 | 7.69 | 10.42 B$  |
| 2025-07-22 | 8.17 | 10.35 B$  |
| 2025-04-22 | 3.33 | 9.47 B$   |
| 2024-10-24 | 7.02 | 10.00 B$  |
| 2025-10-21 | 7.02 | 10.00 B$  |

**Analysis:**

*   Revenue figures show inconsistent growth.
*   The EPS (Earnings Per Share) varies significantly across quarters.
*   The most recent EPS (7.69) is within the recent range, but the dip in EPS in 2025-04-22 raises concern.

**6) Financial Information (Revenue & Profitability and Capital & Profitability)**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|----------------|
| 2025-09-30   | $10.42B   | 21.37%         |
| 2025-06-30   | $10.35B   | 21.35%         |
| 2025-03-31   | $9.47B    | 16.69%         |
| 2024-12-31   | $10.69B   | 18.08%         |
| 2024-09-30   | $10.00B   | 21.07%         |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-09-30   | $15.99B   | 6.88% |
| 2025-06-30   | $15.47B   | 7.59% |
| 2025-03-31   | $14.98B   | 3.21% |
| 2024-12-31   | $15.29B   | 8.27% |
| 2024-09-30   | $14.75B   | 6.96% |

**Analysis:**

*   **Revenue & Profitability:** Revenue is fairly consistent, with slight fluctuations.  Profit margins are relatively high, generally above 20%, except for the quarter ending March 31, 2025.
*   **Capital & Profitability:** Equity is growing modestly over time. ROE (Return on Equity) varies, with a significant dip in the quarter ending March 31, 2025, likely related to the lower profit margin in that period.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** NOC has significantly underperformed the S&P 500, indicating a potential issue with the company's growth prospects or market sentiment.
*   **Mixed Signals:** Technical indicators and news events provide mixed signals. Analyst ratings are generally positive.
*   **Financial Health:** Revenue and profitability are generally healthy, although inconsistencies exist.
*   **Recent Concerns:** the expected return of 0.0% compared to S&P 500 is a strong concern.

**Overall Recommendation:**

Given the underperformance compared to the S&P 500, potential investors should perform in-depth research into the causes of the underperformance. They should also focus on the causes of inconsistency displayed in the recent financial health. It is not recommended to invest until further research is performed.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.